BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 4, 2013
View Archived Issues
Researchers report development of a novel murine model of ALS
Read More
Novartis identifies novel tankyrase inhibitor
Read More
Novel eicosapentaenoic acid derivative for the treatment of asthma
Read More
Cancer suicide gene therapy from INSERM shows promise in vivo
Read More
Trovagene's assay for detecting BRAF mutation in urine now available
Read More
Ventana launches automated test to detect BRAF V600E mutations
Read More
DiaMedica reports phase I/II DM-199 data in type 2 diabetes
Read More
DiaVacs commences phase Ib/IIa study of modified dendritic cells for type 1 diabetes
Read More
AIC-292 shows potent anti-HIV-1 activity in vivo and in first-in-human studies
Read More
Treatment with lanreotide leads to substantially prolonged PFS in patients with GEP-NET tumors
Read More
Two lupus organizations form collaboration to identify potential new treatments for the disease
Read More
Taiho Pharmaceutical patents new agents for cancer
Read More
Otsuka Pharmaceutical synthesizes novel monoamine reuptake inhibitors
Read More
New agents for influenza virus disclosed by Gilead Sciences
Read More
Astellas Pharma establishes new organization to oversee external alliance activities
Read More
Scientists at Purdue Pharma disclose new Na(v)1.7 channel blockers
Read More
DCPrime and Janssen collaborate to develop new dendritic cell-based vaccine
Read More
Axikin Pharmaceuticals divulges new MAP3K19 inhibitors
Read More
Trophos gives update on phase II TR-O40303 trial in myocardial infarction
Read More
CureVac and Janssen to collaborate on development of mRNA-based influenza vaccine
Read More
Orexigen Therapeutics submits MAA to EMA for Contrave
Read More
Jublia approved in Canada for the treatment of onychomycosis
Read More
X-Chem expands drug discovery collaboration with AstraZeneca
Read More
Addex Therapeutics reports preclinical data for ADX-71441 in Charcot-Marie-Tooth type 1A disease
Read More
First patient enrolled in phase II istaroxime study
Read More
Duavee approved for vasomotor symptoms and preventing postmenopausal osteoporosis
Read More